Skip to main content
. Author manuscript; available in PMC: 2019 Feb 1.
Published in final edited form as: Pancreas. 2018 Feb;47(2):208–212. doi: 10.1097/MPA.0000000000000985

TABLE 3.

Multivariate Cox Proportional Hazard Models

Characteristic HR (95 % CI) P
Overall Survival
 Smad4 loss tumor* 1.27 (0.84–1.91) 0.26
 Positive surgical margins 2.03 (1.33–3.08) 0.001
 Histologic grade ¾ 1.42 (0.94–2.14) 0.09
 Lymph node ratio 1.46 (1.01–2.10) 0.04
 5-FU based CRT 0.66 (0.34–1.27) 0.21
 Tumor size (cm) 1.22 (1.04–1.44) 0.02
Disease free survival 0.47
 Smad4 loss tumor* 1.15 (0.79–1.68) 0.007
 Positive surgical margins 1.75 (1.17–2.61) 0.01
 Histologic grade 3/4 1.61 (1.10–2.35) 0.003
 Lymph node ratio 2.98 (1.44–6.18) 0.11
 5-FU based CRT 0.59 (0.30–1.13) 0.01
*

By immunolabeling

5-FU indicates 5 Fluorouracil; CRT – chemoradiation therapy